ID   KS6A5_HUMAN             Reviewed;         802 AA.
AC   O75582; B7Z2Y5; O95316; Q96AF7;
DT   24-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   12-OCT-2022, entry version 213.
DE   RecName: Full=Ribosomal protein S6 kinase alpha-5;
DE            Short=S6K-alpha-5;
DE            EC=2.7.11.1;
DE   AltName: Full=90 kDa ribosomal protein S6 kinase 5;
DE   AltName: Full=Nuclear mitogen- and stress-activated protein kinase 1;
DE   AltName: Full=RSK-like protein kinase;
DE            Short=RSKL;
GN   Name=RPS6KA5; Synonyms=MSK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAC69577.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, ACTIVITY REGULATION,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF ASP-195 AND
RP   ASP-565.
RC   TISSUE=Pancreas {ECO:0000269|PubMed:9687510};
RX   PubMed=9687510; DOI=10.1093/emboj/17.15.4426;
RA   Deak M., Clifton A.D., Lucocq J.M., Alessi D.R.;
RT   "Mitogen- and stress-activated protein kinase-1 (MSK1) is directly
RT   activated by MAPK and SAPK2/p38, and may mediate activation of CREB.";
RL   EMBO J. 17:4426-4441(1998).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta {ECO:0000269|PubMed:9873047};
RX   PubMed=9873047; DOI=10.1074/jbc.274.2.1026;
RA   New L., Zhao M., Li Y., Bassett W.W., Feng Y., Ludwig S., Padova F.D.,
RA   Gram H., Han J.;
RT   "Cloning and characterization of RLPK, a novel RSK-related protein
RT   kinase.";
RL   J. Biol. Chem. 274:1026-1032(1999).
RN   [3] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHROMOSOMAL LOCATION.
RX   PubMed=10702687; DOI=10.1159/000015441;
RA   Jiang C., Yu L., Tu Q., Zhao Y., Zhang H., Zhao S.;
RT   "Assignment of a member of the ribosomal protein S6 kinase family, RPS6KA5,
RT   to human chromosome 14q31-q32.1 by radiation hybrid mapping.";
RL   Cytogenet. Cell Genet. 87:261-262(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Caudate nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta {ECO:0000312|EMBL:AAH17187.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION.
RX   PubMed=11909979; DOI=10.1128/mcb.22.8.2871-2881.2002;
RA   Wiggin G.R., Soloaga A., Foster J.M., Murray-Tait V., Cohen P.,
RA   Arthur J.S.;
RT   "MSK1 and MSK2 are required for the mitogen- and stress-induced
RT   phosphorylation of CREB and ATF1 in fibroblasts.";
RL   Mol. Cell. Biol. 22:2871-2881(2002).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH RELA.
RX   PubMed=12628924; DOI=10.1093/emboj/cdg139;
RA   Vermeulen L., De Wilde G., Van Damme P., Vanden Berghe W., Haegeman G.;
RT   "Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and
RT   stress-activated protein kinase-1 (MSK1).";
RL   EMBO J. 22:1313-1324(2003).
RN   [9]
RP   FUNCTION IN PHOSPHORYLATION OF HISTONE H3 AND HMGN1/HMG14.
RX   PubMed=12773393; DOI=10.1093/emboj/cdg273;
RA   Soloaga A., Thomson S., Wiggin G.R., Rampersaud N., Dyson M.H.,
RA   Hazzalin C.A., Mahadevan L.C., Arthur J.S.;
RT   "MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of
RT   histone H3 and HMG-14.";
RL   EMBO J. 22:2788-2797(2003).
RN   [10]
RP   FUNCTION IN PHOSPHORYLATION OF STAT3.
RX   PubMed=12763138; DOI=10.1016/s0301-472x(03)00045-6;
RA   Wierenga A.T., Vogelzang I., Eggen B.J., Vellenga E.;
RT   "Erythropoietin-induced serine 727 phosphorylation of STAT3 in erythroid
RT   cells is mediated by a MEK-, ERK-, and MSK1-dependent pathway.";
RL   Exp. Hematol. 31:398-405(2003).
RN   [11]
RP   FUNCTION IN PHOSPHORYLATION OF ETV1/ER81, AND INTERACTION WITH CREBBP AND
RP   EP300.
RX   PubMed=12569367; DOI=10.1038/sj.onc.1206185;
RA   Janknecht R.;
RT   "Regulation of the ER81 transcription factor and its coactivators by
RT   mitogen- and stress-activated protein kinase 1 (MSK1).";
RL   Oncogene 22:746-755(2003).
RN   [12]
RP   FUNCTION IN PHOSPHORYLATION OF HISTONE H2A.
RX   PubMed=15010469; DOI=10.1074/jbc.m400099200;
RA   Zhang Y., Griffin K., Mondal N., Parvin J.D.;
RT   "Phosphorylation of histone H2A inhibits transcription on chromatin
RT   templates.";
RL   J. Biol. Chem. 279:21866-21872(2004).
RN   [13]
RP   ACTIVITY REGULATION, PHOSPHORYLATION AT SER-212; SER-360; SER-376; SER-381;
RP   THR-581; SER-750; SER-752 AND SER-758, AND MUTAGENESIS OF SER-212; SER-360;
RP   SER-376 AND THR-581.
RX   PubMed=15568999; DOI=10.1042/bj20041501;
RA   McCoy C.E., Campbell D.G., Deak M., Bloomberg G.B., Arthur J.S.C.;
RT   "MSK1 activity is controlled by multiple phosphorylation sites.";
RL   Biochem. J. 387:507-517(2005).
RN   [14]
RP   PHOSPHORYLATION AT SER-647; SER-657; SER-695 AND THR-700, AND MUTAGENESIS
RP   OF THR-700.
RX   PubMed=17117922; DOI=10.1042/bj20061183;
RA   McCoy C.E., Macdonald A., Morrice N.A., Campbell D.G., Deak M., Toth R.,
RA   McIlrath J., Arthur J.S.;
RT   "Identification of novel phosphorylation sites in MSK1 by precursor ion
RT   scanning MS.";
RL   Biochem. J. 402:491-501(2007).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18511904; DOI=10.1038/emboj.2008.95;
RA   Beck I.M., Vanden Berghe W., Vermeulen L., Bougarne N., Vander Cruyssen B.,
RA   Haegeman G., De Bosscher K.;
RT   "Altered subcellular distribution of MSK1 induced by glucocorticoids
RT   contributes to NF-kappaB inhibition.";
RL   EMBO J. 27:1682-1693(2008).
RN   [16]
RP   REVIEW ON FUNCTION.
RX   PubMed=18508628; DOI=10.2741/3122;
RA   Arthur J.S.;
RT   "MSK activation and physiological roles.";
RL   Front. Biosci. 13:5866-5879(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-376, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   REVIEW ON FUNCTION.
RX   PubMed=19464896; DOI=10.1016/j.tibs.2009.02.007;
RA   Vermeulen L., Vanden Berghe W., Beck I.M., De Bosscher K., Haegeman G.;
RT   "The versatile role of MSKs in transcriptional regulation.";
RL   Trends Biochem. Sci. 34:311-318(2009).
RN   [19]
RP   UBIQUITINATION.
RX   PubMed=20596523; DOI=10.1371/journal.pone.0011332;
RA   Del Rincon S.V., Rogers J., Widschwendter M., Sun D., Sieburg H.B.,
RA   Spruck C.;
RT   "Development and validation of a method for profiling post-translational
RT   modification activities using protein microarrays.";
RL   PLoS ONE 5:E11332-E11332(2010).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-376 AND SER-381, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [22]
RP   FUNCTION IN PHOSPHORYLATION OF TRIM7.
RX   PubMed=25851810; DOI=10.1038/ncomms7782;
RA   Chakraborty A., Diefenbacher M.E., Mylona A., Kassel O., Behrens A.;
RT   "The E3 ubiquitin ligase Trim7 mediates c-Jun/AP-1 activation by Ras
RT   signalling.";
RL   Nat. Commun. 6:6782-6782(2015).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 2-348.
RX   PubMed=15274926; DOI=10.1016/j.str.2004.02.040;
RA   Smith K.J., Carter P.S., Bridges A., Horrocks P., Lewis C., Pettman G.,
RA   Clarke A., Brown M., Hughes J., Wilkinson M., Bax B., Reith A.;
RT   "The structure of MSK1 reveals a novel autoinhibitory conformation for a
RT   dual kinase protein.";
RL   Structure 12:1067-1077(2004).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 414-738.
RX   PubMed=20382163; DOI=10.1016/j.jmb.2010.03.064;
RA   Malakhova M., D'Angelo I., Kim H.G., Kurinov I., Bode A.M., Dong Z.;
RT   "The crystal structure of the active form of the C-terminal kinase domain
RT   of mitogen- and stress-activated protein kinase 1.";
RL   J. Mol. Biol. 399:41-52(2010).
RN   [25]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASN-554; LEU-574 AND CYS-599.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase that is required for the
CC       mitogen or stress-induced phosphorylation of the transcription factors
CC       CREB1 and ATF1 and for the regulation of the transcription factors
CC       RELA, STAT3 and ETV1/ER81, and that contributes to gene activation by
CC       histone phosphorylation and functions in the regulation of inflammatory
CC       genes (PubMed:11909979, PubMed:12569367, PubMed:12763138,
CC       PubMed:9687510, PubMed:18511904, PubMed:9873047). Phosphorylates CREB1
CC       and ATF1 in response to mitogenic or stress stimuli such as UV-C
CC       irradiation, epidermal growth factor (EGF) and anisomycin
CC       (PubMed:11909979, PubMed:9873047). Plays an essential role in the
CC       control of RELA transcriptional activity in response to TNF and upon
CC       glucocorticoid, associates in the cytoplasm with the glucocorticoid
CC       receptor NR3C1 and contributes to RELA inhibition and repression of
CC       inflammatory gene expression (PubMed:12628924, PubMed:18511904). In
CC       skeletal myoblasts is required for phosphorylation of RELA at 'Ser-276'
CC       during oxidative stress (PubMed:12628924). In erythropoietin-stimulated
CC       cells, is necessary for the 'Ser-727' phosphorylation of STAT3 and
CC       regulation of its transcriptional potential (PubMed:12763138).
CC       Phosphorylates ETV1/ER81 at 'Ser-191' and 'Ser-216', and thereby
CC       regulates its ability to stimulate transcription, which may be
CC       important during development and breast tumor formation
CC       (PubMed:12569367). Directly represses transcription via phosphorylation
CC       of 'Ser-1' of histone H2A (PubMed:15010469). Phosphorylates 'Ser-10' of
CC       histone H3 in response to mitogenics, stress stimuli and EGF, which
CC       results in the transcriptional activation of several immediate early
CC       genes, including proto-oncogenes c-fos/FOS and c-jun/JUN
CC       (PubMed:12773393). May also phosphorylate 'Ser-28' of histone H3
CC       (PubMed:12773393). Mediates the mitogen- and stress-induced
CC       phosphorylation of high mobility group protein 1 (HMGN1/HMG14)
CC       (PubMed:12773393). In lipopolysaccharide-stimulated primary
CC       macrophages, acts downstream of the Toll-like receptor TLR4 to limit
CC       the production of pro-inflammatory cytokines (By similarity). Functions
CC       probably by inducing transcription of the MAP kinase phosphatase DUSP1
CC       and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and
CC       ATF1 transcription factors (By similarity). Plays a role in neuronal
CC       cell death by mediating the downstream effects of excitotoxic injury
CC       (By similarity). Phosphorylates TRIM7 at 'Ser-107' in response to
CC       growth factor signaling via the MEK/ERK pathway, thereby stimulating
CC       its ubiquitin ligase activity (PubMed:25851810).
CC       {ECO:0000250|UniProtKB:Q8C050, ECO:0000269|PubMed:11909979,
CC       ECO:0000269|PubMed:12569367, ECO:0000269|PubMed:12628924,
CC       ECO:0000269|PubMed:12763138, ECO:0000269|PubMed:12773393,
CC       ECO:0000269|PubMed:15010469, ECO:0000269|PubMed:18511904,
CC       ECO:0000269|PubMed:25851810, ECO:0000269|PubMed:9687510,
CC       ECO:0000269|PubMed:9873047}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:12628924, ECO:0000269|PubMed:9687510,
CC         ECO:0000269|PubMed:9873047};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:12628924,
CC         ECO:0000269|PubMed:9687510, ECO:0000269|PubMed:9873047};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:12628924, ECO:0000269|PubMed:9687510,
CC         ECO:0000269|PubMed:9873047};
CC   -!- ACTIVITY REGULATION: Activated by phosphorylation at Ser-360, Thr-581
CC       and Thr-700 by MAPK1/ERK2, MAPK3/ERK1 and MAPK14/p38-alpha, and by
CC       further autophosphorylation of Ser-212, Ser-376 and Ser-381 by the
CC       activated C-terminal kinase domain. The active N-terminal kinase domain
CC       finally phosphorylates downstream substrates, as well as Ser-750, Ser-
CC       752 and Ser-758 in its own C-terminal region.
CC       {ECO:0000269|PubMed:15568999, ECO:0000269|PubMed:9687510}.
CC   -!- SUBUNIT: Forms a complex with either MAPK1/ERK2 or MAPK3/ERK1 in
CC       quiescent cells which transiently dissociates following mitogenic
CC       stimulation. Also associates with MAPK14/p38-alpha. Activated RPS6KA5
CC       associates with and phosphorylates the NF-kappa-B p65 subunit RELA.
CC       Interacts with CREBBP and EP300. {ECO:0000269|PubMed:12569367,
CC       ECO:0000269|PubMed:12628924}.
CC   -!- INTERACTION:
CC       O75582; Q9UI47-2: CTNNA3; NbExp=3; IntAct=EBI-73869, EBI-11962928;
CC       O75582; Q9Y4C1: KDM3A; NbExp=3; IntAct=EBI-73869, EBI-2515339;
CC       O75582; Q9NYL2: MAP3K20; NbExp=4; IntAct=EBI-73869, EBI-602273;
CC       O75582-1; Q9Y4C1: KDM3A; NbExp=3; IntAct=EBI-16135973, EBI-2515339;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Predominantly nuclear.
CC       Exported into cytoplasm in response to glucocorticoid.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O75582-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75582-2; Sequence=VSP_041837, VSP_041838;
CC       Name=3;
CC         IsoId=O75582-3; Sequence=VSP_057410;
CC   -!- TISSUE SPECIFICITY: Widely expressed with high levels in heart, brain
CC       and placenta. Less abundant in lung, kidney and liver.
CC       {ECO:0000269|PubMed:9687510, ECO:0000269|PubMed:9873047}.
CC   -!- PTM: Ser-376 and Thr-581 phosphorylation is required for kinase
CC       activity. Ser-376 and Ser-212 are autophosphorylated by the C-terminal
CC       kinase domain, and their phosphorylation is essential for the catalytic
CC       activity of the N-terminal kinase domain. Phosphorylated at Ser-360,
CC       Thr-581 and Thr-700 by MAPK1/ERK2, MAPK3/ERK1 and MAPK14/p38-alpha.
CC       Autophosphorylated at Ser-750, Ser-752 and Ser-758 by the N-terminal
CC       kinase domain. {ECO:0000269|PubMed:15568999,
CC       ECO:0000269|PubMed:17117922}.
CC   -!- PTM: Ubiquitinated. {ECO:0000269|PubMed:20596523}.
CC   -!- MISCELLANEOUS: Enzyme activity requires the presence of both kinase
CC       domains. {ECO:0000269|PubMed:9687510}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. S6 kinase subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC69577.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF074393; AAC31171.1; -; mRNA.
DR   EMBL; AF080000; AAD23915.1; -; mRNA.
DR   EMBL; AF090421; AAC69577.1; ALT_FRAME; mRNA.
DR   EMBL; AK295266; BAH12021.1; -; mRNA.
DR   EMBL; AL121784; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133454; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL159191; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC017187; AAH17187.1; -; mRNA.
DR   CCDS; CCDS45149.1; -. [O75582-2]
DR   CCDS; CCDS81839.1; -. [O75582-3]
DR   CCDS; CCDS9893.1; -. [O75582-1]
DR   PIR; T13149; T13149.
DR   RefSeq; NP_001309164.1; NM_001322235.1. [O75582-3]
DR   RefSeq; NP_001309166.1; NM_001322237.1. [O75582-3]
DR   RefSeq; NP_004746.2; NM_004755.3. [O75582-1]
DR   RefSeq; NP_872198.1; NM_182398.2. [O75582-2]
DR   PDB; 1VZO; X-ray; 1.80 A; A=2-348.
DR   PDB; 3KN5; X-ray; 2.40 A; A/B=414-738.
DR   PDB; 3KN6; X-ray; 2.00 A; A/B=414-738.
DR   PDBsum; 1VZO; -.
DR   PDBsum; 3KN5; -.
DR   PDBsum; 3KN6; -.
DR   AlphaFoldDB; O75582; -.
DR   SMR; O75582; -.
DR   BioGRID; 114676; 88.
DR   DIP; DIP-30894N; -.
DR   ELM; O75582; -.
DR   IntAct; O75582; 86.
DR   MINT; O75582; -.
DR   STRING; 9606.ENSP00000479667; -.
DR   BindingDB; O75582; -.
DR   ChEMBL; CHEMBL4237; -.
DR   DrugCentral; O75582; -.
DR   GuidetoPHARMACOLOGY; 1523; -.
DR   GlyGen; O75582; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O75582; -.
DR   PhosphoSitePlus; O75582; -.
DR   BioMuta; RPS6KA5; -.
DR   EPD; O75582; -.
DR   jPOST; O75582; -.
DR   MassIVE; O75582; -.
DR   MaxQB; O75582; -.
DR   PaxDb; O75582; -.
DR   PeptideAtlas; O75582; -.
DR   PRIDE; O75582; -.
DR   ProteomicsDB; 50098; -. [O75582-1]
DR   ProteomicsDB; 50099; -. [O75582-2]
DR   ProteomicsDB; 6477; -.
DR   Antibodypedia; 83; 964 antibodies from 41 providers.
DR   DNASU; 9252; -.
DR   Ensembl; ENST00000418736.6; ENSP00000402787.2; ENSG00000100784.12. [O75582-2]
DR   Ensembl; ENST00000536315.6; ENSP00000442803.2; ENSG00000100784.12. [O75582-3]
DR   Ensembl; ENST00000614987.5; ENSP00000479667.1; ENSG00000100784.12. [O75582-1]
DR   GeneID; 9252; -.
DR   KEGG; hsa:9252; -.
DR   MANE-Select; ENST00000614987.5; ENSP00000479667.1; NM_004755.4; NP_004746.2.
DR   UCSC; uc001xys.4; human. [O75582-1]
DR   UCSC; uc010twi.3; human.
DR   CTD; 9252; -.
DR   DisGeNET; 9252; -.
DR   GeneCards; RPS6KA5; -.
DR   HGNC; HGNC:10434; RPS6KA5.
DR   HPA; ENSG00000100784; Low tissue specificity.
DR   MIM; 603607; gene.
DR   neXtProt; NX_O75582; -.
DR   OpenTargets; ENSG00000100784; -.
DR   PharmGKB; PA34849; -.
DR   VEuPathDB; HostDB:ENSG00000100784; -.
DR   eggNOG; KOG0603; Eukaryota.
DR   GeneTree; ENSGT00940000156886; -.
DR   InParanoid; O75582; -.
DR   OMA; IMQRICR; -.
DR   OrthoDB; 181575at2759; -.
DR   PhylomeDB; O75582; -.
DR   TreeFam; TF313438; -.
DR   PathwayCommons; O75582; -.
DR   Reactome; R-HSA-198753; ERK/MAPK targets.
DR   Reactome; R-HSA-199920; CREB phosphorylation.
DR   Reactome; R-HSA-375165; NCAM signaling for neurite out-growth.
DR   Reactome; R-HSA-437239; Recycling pathway of L1.
DR   Reactome; R-HSA-5621575; CD209 (DC-SIGN) signaling.
DR   SABIO-RK; O75582; -.
DR   SignaLink; O75582; -.
DR   SIGNOR; O75582; -.
DR   BioGRID-ORCS; 9252; 8 hits in 1108 CRISPR screens.
DR   ChiTaRS; RPS6KA5; human.
DR   EvolutionaryTrace; O75582; -.
DR   GeneWiki; RPS6KA5; -.
DR   GenomeRNAi; 9252; -.
DR   Pharos; O75582; Tchem.
DR   PRO; PR:O75582; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; O75582; protein.
DR   Bgee; ENSG00000100784; Expressed in secondary oocyte and 204 other tissues.
DR   ExpressionAtlas; O75582; baseline and differential.
DR   Genevisible; O75582; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0044024; F:histone kinase activity (H2A-S1 specific); IDA:UniProtKB.
DR   GO; GO:0035175; F:histone kinase activity (H3-S10 specific); IMP:UniProtKB.
DR   GO; GO:0044022; F:histone kinase activity (H3-S28 specific); IMP:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; TAS:Reactome.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0070498; P:interleukin-1-mediated signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:0001818; P:negative regulation of cytokine production; TAS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0032793; P:positive regulation of CREB transcription factor activity; TAS:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:BHF-UCL.
DR   GO; GO:0043687; P:post-translational protein modification; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; IDA:UniProtKB.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR016239; Ribosomal_S6_kinase_II.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 2.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000606; Ribsml_S6_kin_2; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 2.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 2.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 2.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cytoplasm;
KW   Inflammatory response; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Stress response; Transferase;
KW   Ubl conjugation.
FT   CHAIN           1..802
FT                   /note="Ribosomal protein S6 kinase alpha-5"
FT                   /id="PRO_0000086207"
FT   DOMAIN          49..318
FT                   /note="Protein kinase 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          319..387
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   DOMAIN          426..687
FT                   /note="Protein kinase 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..23
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          741..802
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        752..802
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        177
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        544
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250"
FT   BINDING         55..63
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         81
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         432..440
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         455
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         212
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:15568999"
FT   MOD_RES         360
FT                   /note="Phosphoserine; by MAPK1, MAPK3 and MAPK14"
FT                   /evidence="ECO:0000269|PubMed:15568999"
FT   MOD_RES         376
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:15568999,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231"
FT   MOD_RES         381
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:15568999,
FT                   ECO:0007744|PubMed:20068231"
FT   MOD_RES         581
FT                   /note="Phosphothreonine; by MAPK1, MAPK3 and MAPK14"
FT                   /evidence="ECO:0000269|PubMed:15568999"
FT   MOD_RES         647
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:17117922"
FT   MOD_RES         657
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:17117922"
FT   MOD_RES         691
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8C050"
FT   MOD_RES         695
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:17117922"
FT   MOD_RES         700
FT                   /note="Phosphothreonine; by MAPK1, MAPK3 and MAPK14"
FT                   /evidence="ECO:0000269|PubMed:17117922"
FT   MOD_RES         750
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:15568999"
FT   MOD_RES         752
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:15568999"
FT   MOD_RES         758
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:15568999"
FT   MOD_RES         798
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8C050"
FT   VAR_SEQ         1..79
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_057410"
FT   VAR_SEQ         549
FT                   /note="N -> V (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_041837"
FT   VAR_SEQ         550..802
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_041838"
FT   VARIANT         190
FT                   /note="H -> R (in dbSNP:rs34699345)"
FT                   /id="VAR_051634"
FT   VARIANT         554
FT                   /note="D -> N (in dbSNP:rs55911249)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040634"
FT   VARIANT         574
FT                   /note="P -> L (in dbSNP:rs34604933)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040635"
FT   VARIANT         599
FT                   /note="Y -> C (in dbSNP:rs55968863)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040636"
FT   MUTAGEN         195
FT                   /note="D->A: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:9687510"
FT   MUTAGEN         212
FT                   /note="S->A: Inactivates the N-terminal kinase domain."
FT                   /evidence="ECO:0000269|PubMed:15568999"
FT   MUTAGEN         360
FT                   /note="S->A: Decreases kinase activity by 60% in response
FT                   to PMA and UV-C."
FT                   /evidence="ECO:0000269|PubMed:15568999"
FT   MUTAGEN         376
FT                   /note="S->A: Loss of kinase activity, and decreases the
FT                   phosphorylation of S-360 and T-581."
FT                   /evidence="ECO:0000269|PubMed:15568999"
FT   MUTAGEN         565
FT                   /note="D->A: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:9687510"
FT   MUTAGEN         581
FT                   /note="T->A: Loss of kinase activity, and blocks
FT                   phosphorylation of S-212; S-376 and S-381 in response to
FT                   PMA and UV-C."
FT                   /evidence="ECO:0000269|PubMed:15568999"
FT   MUTAGEN         700
FT                   /note="T->A,D: Strongly reduces phosphorylation of T-581 in
FT                   response to PMA and UV-C."
FT                   /evidence="ECO:0000269|PubMed:17117922"
FT   CONFLICT        452..453
FT                   /note="FA -> LQ (in Ref. 3; AAC69577)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        532
FT                   /note="V -> L (in Ref. 3; AAC69577)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        538
FT                   /note="V -> L (in Ref. 3; AAC69577)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        757..758
FT                   /note="SS -> RG (in Ref. 3; AAC69577)"
FT                   /evidence="ECO:0000305"
FT   STRAND          26..31
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   HELIX           46..48
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   STRAND          49..57
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   TURN            58..60
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   STRAND          61..68
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   TURN            72..75
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   STRAND          77..94
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   HELIX           95..97
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   HELIX           101..109
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   STRAND          117..123
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   STRAND          126..131
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   HELIX           139..146
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   HELIX           151..170
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   HELIX           180..182
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   STRAND          183..185
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   STRAND          191..194
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   STRAND          196..201
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   HELIX           204..210
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   HELIX           212..214
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   HELIX           222..225
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   HELIX           235..250
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   HELIX           264..273
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   HELIX           284..293
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   HELIX           298..300
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   TURN            306..308
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   HELIX           309..313
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   HELIX           316..318
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   HELIX           323..327
FT                   /evidence="ECO:0007829|PDB:1VZO"
FT   HELIX           418..422
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   STRAND          423..425
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   STRAND          432..435
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   STRAND          438..445
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   TURN            446..448
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   STRAND          451..458
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   HELIX           459..461
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   HELIX           462..474
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   TURN            475..477
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   STRAND          484..489
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   STRAND          491..498
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   HELIX           506..512
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   HELIX           518..537
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   HELIX           547..549
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   STRAND          550..553
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   STRAND          560..563
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   HELIX           602..617
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   HELIX           634..641
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   TURN            642..644
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   HELIX           651..654
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   HELIX           658..668
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   TURN            672..674
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   TURN            678..680
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   HELIX           685..687
FT                   /evidence="ECO:0007829|PDB:3KN6"
FT   HELIX           700..728
FT                   /evidence="ECO:0007829|PDB:3KN6"
SQ   SEQUENCE   802 AA;  89865 MW;  76C27D0F6639BFA4 CRC64;
     MEEEGGSSGG AAGTSADGGD GGEQLLTVKH ELRTANLTGH AEKVGIENFE LLKVLGTGAY
     GKVFLVRKIS GHDTGKLYAM KVLKKATIVQ KAKTTEHTRT ERQVLEHIRQ SPFLVTLHYA
     FQTETKLHLI LDYINGGELF THLSQRERFT EHEVQIYVGE IVLALEHLHK LGIIYRDIKL
     ENILLDSNGH VVLTDFGLSK EFVADETERA YSFCGTIEYM APDIVRGGDS GHDKAVDWWS
     LGVLMYELLT GASPFTVDGE KNSQAEISRR ILKSEPPYPQ EMSALAKDLI QRLLMKDPKK
     RLGCGPRDAD EIKEHLFFQK INWDDLAAKK VPAPFKPVIR DELDVSNFAE EFTEMDPTYS
     PAALPQSSEK LFQGYSFVAP SILFKRNAAV IDPLQFHMGV ERPGVTNVAR SAMMKDSPFY
     QHYDLDLKDK PLGEGSFSIC RKCVHKKSNQ AFAVKIISKR MEANTQKEIT ALKLCEGHPN
     IVKLHEVFHD QLHTFLVMEL LNGGELFERI KKKKHFSETE ASYIMRKLVS AVSHMHDVGV
     VHRDLKPENL LFTDENDNLE IKIIDFGFAR LKPPDNQPLK TPCFTLHYAA PELLNQNGYD
     ESCDLWSLGV ILYTMLSGQV PFQSHDRSLT CTSAVEIMKK IKKGDFSFEG EAWKNVSQEA
     KDLIQGLLTV DPNKRLKMSG LRYNEWLQDG SQLSSNPLMT PDILGSSGAA VHTCVKATFH
     AFNKYKREGF CLQNVDKAPL AKRRKMKKTS TSTETRSSSS ESSHSSSSHS HGKTTPTKTL
     QPSNPADSNN PETLFQFSDS VA
//
